# FDA Inspection 1232731 - Exeltis USA, Inc. - November 15, 2024

Source: https://www.keypedia.com/records/fda_inspections/exeltis-usa-inc/b86074bd-b3c8-4819-9049-13279bf8a78d
Source feed: FDA_Inspections

> FDA Inspection 1232731 for Exeltis USA, Inc. on November 15, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1232731
- Company Name: Exeltis USA, Inc.
- Inspection Date: 2024-11-15
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1250586 - 2025-07-02](https://www.keypedia.com/records/fda_inspections/exeltis-usa-inc/675c00a3-94f3-4fb5-b4c0-26375be77d4b)
- [FDA Inspection 1250586 - 2025-07-02](https://www.keypedia.com/records/fda_inspections/exeltis-usa-inc/a35bcf11-1032-4fdb-af70-333e22692648)
- [FDA Inspection 1232731 - 2024-11-15](https://www.keypedia.com/records/fda_inspections/exeltis-usa-inc/90fe4972-d279-4bf5-8705-4913c115dc11)
- [FDA Inspection 1014140 - 2017-06-06](https://www.keypedia.com/records/fda_inspections/exeltis-usa-inc/906d22db-852b-481c-80ce-fbc019fe6546)
- [FDA Inspection 1014140 - 2017-06-06](https://www.keypedia.com/records/fda_inspections/exeltis-usa-inc/9ab7c541-da1d-41e2-8960-4fde32f2506c)

Company: https://www.keypedia.com/companies/exeltis-usa-inc/d5a2dfa6-39bc-4768-b3f4-5c0630d2dc8f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c